Cite
HARVARD Citation
Contin, M. et al. (2018). Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis. Clinical neuropharmacology. 41 (5), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Contin, M. et al. (2018). Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis. Clinical neuropharmacology. 41 (5), p. . [Online].